Article

Prodizen to Participate in KIMES 2026, Unveiling PRP-Based Regenerative Medicine Solutions and Key GFC Lineup

  • 작성일 : 2026.03.11
  • 조회수 : 1

7fbb46472b56ab027cf3553c443d7107_1773367145_2406.jpg
 

Cell therapy company Prodizen will participate in KIMES 2026 (the 41st Korea International Medical Equipment & Hospital Equipment Show) to showcase its diverse PRP (platelet-rich plasma)-based product line and gaming medical solutions, and plans to expand overseas.

KIMES 2026, held at COEX in Seoul from March 19th to 22nd, is Korea's largest medical industry exhibition showcasing the latest technologies and industries in medical devices, hospital facilities, and digital care. This year, the exhibition will be complemented by related programs such as export consultations, medical tourism associations, innovative company pitching, and European protection systems.


Prodizen, which has been dedicated to the PRP and BMC fields for over a decade, operates its own production facility, not simply as an OEM (original equipment manufacturer), and has established a rigorous quality control system. At KIMES, booth B121 will showcase a diverse lineup of flagship products, including the customized anti-aging injection GFC+, as well as PROSYS PRP, PROSYS ACT 10, PRS, and BMC-S30.


Prodizen's core competitive edge, the "PRP tube," is a medical consumable that uses a patient's own blood to quickly and reliably separate and concentrate platelets. Its ability to secure high concentrations of platelets through a short centrifugation process of less than three minutes ensures superior clinical usability. Designed to achieve high platelet concentrations within a three-minute centrifugation process, the tube enhances treatment efficiency.


Based on this technological prowess, Prodizen has obtained US FDA Class II certification, European CE certification, and numerous domestic and international patents. It also achieved the remarkable feat of winning the "Million Dollar Export Tower" award for a single PRP product. Furthermore, the company plans to use this exhibition as an opportunity to focus on expanding its network in the Southeast Asian market, particularly among its overseas clients.


Meanwhile, interactive events will also be held for visitors to KIMES 2026. Visitors to the Prodizen B121 booth will be invited to a gacha event for those who follow the company's official Instagram account and subscribe to its YouTube channel. Participants will receive various prizes, including a coffee machine, diffuser, and humidifier. This event aims to strengthen on-site communication with visitors to the exhibition booth.


A Prodizen official said, "Based on our proven product capabilities that have passed strict global approvals, including those from the FDA, we plan to widely publicize our excellent product lineup at KIMES 2026 and establish a solid bridgehead for entering the Southeast Asian market." They added, "We will continue to participate in various domestic and international academic conferences and exhibitions to expand our global network and further solidify our position as a leading company in the cell therapy field."


Reporter Kim Eun-ji admin@medisobizanews.com